Research Paper Volume 13, Issue 16 pp 20438—20467
Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer
Figure 5. Prognostic values of ceruloplasmin in BRCA patients. (A) Survival curves from Kaplan–Meier Plotter indicated that higher ceruloplasmin expression was related to worse OS, RFS, DMFS and PPS in patients with BRCA. (B) Survival curves from bc-GenExMiner v4.5 showed the prognostic value of ceruloplasmin in BRCA patients based on OS, DFS and DMFS. (C) The DMFS and RFS in BRCA cohorts using the PrognoScan database. (D) ROC curve of ceruloplasmin mRNA expression in BRCA.